AESKULISA® CROHN’S-CHECK
ES UN ENZIMOINMUNOENSAYO EN FASE SÓLIDA (ELISA) QUE EMPLEA MANANO ELEVADAMENTE PURIFICADO PARA LA DETECCIÓN COMBINADA CUANTITATIVA Y CUALITATIVA DE ANTICUERPOS ANTI-SACCHAROMYCES CEREVISIAE IGA E IGG (ASCA) EN SUERO HUMANO.
IT IS A SOLID-PHASE ENZYME IMMUNOASSAY (ELISA) THAT USES HIGHLY PURIFIED MANNAN FOR THE COMBINED QUANTITATIVE AND QUALITATIVE DETECTION OF ANTI-SACCHAROMYCES CEREVISIAE IGA AND IGG (ASCA) ANTIBODIES IN HUMAN SERUM.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVO PARA LA DETECCIÓN DE ANTICUERPO ANTI-SACCHAROMYCES CEREVISIAE IGA E IGG (ASCA)
- Trade Name (English)
- REAGENT FOR THE DETECTION OF ANTI-SACCHAROMYCES CEREVISIAE IGA AND IGG ANTIBODY (ASCA)
- Analysis ID
- 1335R2019 SSA
- Registration Date
- July 16, 2019
- Name (Spanish)
- GRIFOLS MÉXICO, S.A. DE C.V.
- Name (English)
- GRIFOLS MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for AESKULISA® CROHN’S-CHECK (AESKULISA® CROHN'S-CHECK) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1335R2019 SSA and manufactured by GRIFOLS MÉXICO, S.A. DE C.V.. The device was registered on July 16, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.